Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0531 | 0.0632 | 0.0632 |
Echinococcus multilocularis | MAM | 0.0531 | 0.0632 | 0.0944 |
Loa Loa (eye worm) | TK protein kinase | 0.3105 | 0.669 | 0.6692 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0272 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | hypothetical protein | 0.303 | 0.6513 | 0.6516 |
Brugia malayi | Protein kinase domain containing protein | 0.3105 | 0.669 | 0.669 |
Loa Loa (eye worm) | TK/ALK protein kinase | 0.451 | 0.9996 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0531 | 0.0632 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.3904 | 0.8569 | 0.8572 |
Onchocerca volvulus | 0.0597 | 0.0786 | 1 | |
Echinococcus multilocularis | tyrosine protein kinase | 0.3105 | 0.669 | 1 |
Echinococcus granulosus | tyrosine protein kinase | 0.3105 | 0.669 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0272 | 0.0022 | 0.0022 |
Loa Loa (eye worm) | hypothetical protein | 0.0531 | 0.0632 | 0.0632 |
Loa Loa (eye worm) | hypothetical protein | 0.0531 | 0.0632 | 0.0632 |
Echinococcus granulosus | MAM | 0.0531 | 0.0632 | 0.0944 |
Schistosoma mansoni | hypothetical protein | 0.0531 | 0.0632 | 1 |
Brugia malayi | hypothetical protein | 0.0531 | 0.0632 | 0.0632 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 3.16227766 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.